DelveInsight's 'Severe Asthma Pipeline Insight 2024' report provides comprehensive global coverage of pipeline severe asthma ...

Jasper Therapeutics faces financial challenges but strong buy ratings. Read why JSPR stock is poised for growth amid risks ...

USA: Recent findings published in The Journal of Allergy and Clinical Immunology highlight the potential for long-term ...

Over 40 companies are working on more than 50 therapies for severe asthma. The severe asthma market is growing due to a ...

At the recent American College of Allergy, Asthma & Immunology (ACAAI) annual meeting, experts discussed the evolving concept ...

New research from the University of Pittsburgh uncovers how inhaled house dust mites, a common trigger of allergic asthma, ...

BOSTON -- Inhaled corticosteroids (ICS) combined either with formoterol (Foradil) or short-acting beta-agonists (SABA) for asthma treatment were associated with reduced risks of severe exacerbations ...

Researchers at National Jewish Health and colleagues have identified a mechanism involved in the formation of mucus plugs in ...

Scientists at deCODE genetics and collaborators have published a study in the Journal of Allergy and Clinical Immunology ...

DelveInsight's severe asthma pipeline report depicts a robust space with 40+ active players working to develop 50+ pipeline therapies for severe asthma treatment. Key severe asthma companies such ...

Collaborative efforts in R&D are also vital for driving innovation in asthma treatments. Request a sample and discover the recent advances in severe asthma treatment drugs @ Severe Asthma Pipeline ...